Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 1: Non-clinical and clinical insights

Regulatory Toxicology and Pharmacology

Volumn 64, Issue SUPPL. 2, 2012, Pages

  Schorp, Matthias K ^a   Tricker, Anthony R ^a   Dempsey, Ruth ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Biomarkers of exposure; Cigarettes; EHCSS; Electrically Heated Cigarette Smoking System; Harmful and potentially harmful constituents; HPHC; Smoking

Indexed keywords

1,3 BUTADIENE; 2 METHYLANILINE; 2 NAPHTHYLAMINE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 BIPHENYLAMINE; ACROLEIN; BENZENE; BIOLOGICAL MARKER; CARBON MONOXIDE; CIGARETTE SMOKE; MUTAGENIC AGENT; NEUTRAL RED; NICOTINE; PYRENE;

AMES TEST; ARTICLE; CARDIOVASCULAR RISK; CYTOTOXICITY; DEVICE SAFETY; ELECTRICAL EQUIPMENT; ELECTRICALLY HEATED CIGARETTE SMOKING SYSTEM; EQUIPMENT DESIGN; HEALTH HAZARD; HUMAN; IN VITRO STUDY; MUTAGENIC ACTIVITY; NONHUMAN; POPULATION EXPOSURE; PRIORITY JOURNAL; RISK REDUCTION; SALMONELLA TYPHIMURIUM; SMOKING HABIT; TOXICITY TESTING;

BIOLOGICAL MARKERS; CARBON MONOXIDE; CLINICAL TRIALS AS TOPIC; ELECTRICITY; HUMANS; INHALATION EXPOSURE; MUTAGENICITY TESTS; MUTAGENS; NICOTINE; SALMONELLA TYPHIMURIUM; TARS; TOBACCO; TOBACCO PRODUCTS; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM; SALMONELLA TYPHIMURIUM;

EID: 84868342268     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.08.008     Document Type: Article

References (111)

1. Armitage A.K., Dixon M., Frost B.E., Mariner D.C., Sinclair N.M. The effect of inhalation volume and breath-hold duration on the retention of nicotine and solanesol in the human respiratory tract and on subsequent plasma nicotine concentrations curing cigarette smoking. Beitr. Tabakforsch. Int. 2004, 21:240-249.
2. Baker R.R. Smoke generation inside a burning cigarette: modifying combustion to develop cigarettes that may be less hazardous to health. Prog. Energy Combust. Sci. 2006, 32:373-385.
3. Baker R.R., Dixon M. The retention of tobacco smoke constituents in the human respiratory tract. Inhal. Toxicol. 2006, 17:255-294.
4. Benowitz N.L. Pharmacologic aspects of cigarette smoking and nicotine addiction. New Engl. J. Med. 1988, 319:1318-1330.
5. Benowitz N.L., Jacob P., Fong I., Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 1994, 268:296-303.
6. Bjellaas T., Stølen L.H., Haugen M., Paulsen J.E., Alexander J., Lundanes E., Becher G. Urinary acrylamide metabolites as biomarkers for short-term dietary exposure to acrylamide. Food Chem. Toxicol. 2007, 45:1020-1026.
7. Boogaard P.J., van Sittert N.J. Suitability of S-phenyl mercapturic acid and trans-trans-muconic acid as biomarkers for exposure to low concentrations of benzene. Environ. Health Perspect. 1996, 104(Suppl. 6):1151-1157.
8. Borgerding M.F., Klus H. Analysis of complex mixtures-cigarette smoke. Exp. Toxicol. Pathol. 2005, 57(Suppl. 1):43-73.
9. Borgerding M.F., Bodnar J.A., Chung H.L., Mangan P.P., Morrison C.C., Risner C.H., Rogers J.C., Simmons D.F., Uhrig M.S., Wendelboe F.N., Wingate D.E., Winkler L.S. Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 1. Chemical composition of mainstream smoke. Food Chem. Toxicol. 1997, 36:169-182.
10. Brandt H.C.A., Watson W.P. Monitoring human occupational and environmental exposures to polycyclic aromatic compounds. Annal. Occup. Hyg. 2003, 47:349-378.
11. Burns, D.M., 2006. Experience ISO Machine Measurements of Cigarette Yields. Technical Briefing; Conference of the Parties (COP1), Geneva, 7 February 2006. (accessed 27.09.2011). http://www.who.int/tobacco/fctc/TobReg_COP_Burns_2.pdf.
12. Burns D.M., Dybing E., Gray N., Hecht S., Anderson C., Sanner T., O'Connor R., Djordjevic M., Dresler M., Hainaut P., Jarvis M., Oppenhuizen A., Straif K. Mandatory lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob. Control 2008, 17:132-141.
13. Byrd G.D., Davis R.A., Caldwell W.S., Robinson J.H., deBethizy J.D. A further study of FTC yield and nicotine absorption in smokers. Psychopharmacology 1998, 139:291-299.
14. Carmella S.G., Chen M., Han S., Briggs A., Jensen J., Hatsukami D.K., Hecht S.S. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem. Res. Toxicol. 2009, 22:734-741.
15. De Flora S., Balansky R., Gasparini L., Camoirano A. Bacterial mutegenicity of cigarette smoke and its interaction with ethanol. Mutagenesis 1995, 10:47-52.
16. Deyton L., Sharfstein J., Hamburg M. Tobacco product regulation: a public health approach. New Engl. J. Med. 2010, 362:1753-1756.
17. Diana, J.N., Vaught, A., 1990. Research cigarettes. Lexington, University of Kentucky Printing Services.
18. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004, 328:7455-7464.
19. ECLIPSE Expert Panel A safer cigarette? a comparative study. A Consensus Report. Inhal. Toxicol. 2000, 12(Suppl. 5):1-48.
20. Einistö, P., Nohmi, T., Watanabe, M., Ishidate, Jr., M., 1990. Sensitivity of Salmonella typhimurium YG1024 to urine mutagenicity caused by cigarette smoking. Mutat. Res. 245, 87-92.
21. Family Smoking Prevention and Tobacco Control Act (FSPTCA), 2009. Public Law No. 111-31 (June 22, 2009).
22. Feng S., Roethig H.J., Liang Q., Kinser R., Jin Y., Scherer G., Urban M., Engl J., Riedel K. Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans, trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2'-deoxyguanosine and thioethers as biomarkers of exposure to tobacco smoke. Biomarkers 2006, 11:28-52.
23. Fidler J.A., Jarvis M.J., Mindell J., West R. Nicotine intake in cigarette smokers in england: distribution and demographic correlates. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3331-3336.
24. Food and Drug Administration, 2001. Guidance for Industry. Bioanalytical Method Validation. Available at: (accessed 27.09.2011). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
25. Food and Drug Administration, 2012a. FDA's Guidance for Industry " Modified Risk Tobacco Products Applications" Request for Comments Docket No. FDA-2012-D-0071. Available at (accessed May 23, 2012). http://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm297750.htm.
26. Food and Drug Administration, 2012b. Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List. Federal Register Vol. 77, No. 64; pp. 20034-20037 (April 3, 2012). Available at (accessed June 6, 2012). http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM297981.pdf.
27. Fournier J.A., Paine J.B.I. Smoking article wrapper with improved filter. United States patent number 2001, 6(289):898.
28. Frost-Pineda K., Zedler B.K., Liang Q., Roethig H.J. Environmental tobacco smoke (ETS) evaluation of a third-generation electrically heated cigarette smoking system (EHCSS). Regul. Toxicol. Pharmacol. 2008, 52:118-121.
29. Frost-Pineda K., Zedler B.K., Oliveri D., Liang Q., Feng S., Roethig H.J. 12-Week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul. Toxicol. Pharmacol. 2008, 52:111-117.
30. Frost-Pineda K., Zedler B.K., Oliveri D., Feng S., Liang Q., Roethig H.J. Short-term clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul. Toxicol. Pharmacol. 2008, 52:104-110.
31. Fustinoni S., Buratti M., Campo L., Colombi A., Consonni D., Pesatori A.C., Ronzini M., Farmer P., Garte S., Valerio F., Merlo D.F., Bertazzi P.A. Urinary t,t-muconic acid, S-phenylmercapturic acid and benzene as biomarkers of low benzene exposure. Chem. Biol. Interact. 2005, 153-154:253-256.
32. Gilmore A.B., Britton J., Arnott D., Ashcroft R., Jarvis M.J. The place for harm reduction and product regulation in UK tobacco control policy. J. Public Health (Oxf) 2009, 31:3-10.
33. Giovino G.A., Sidney S., Gfroerer J.C., O'Malley P.M., Allen J.A., Richter P.A., Cummings K.M. Epidemiology of menthol cigarette use. Nicotine Tob. Res. 2004, 6(Suppl. 1):S67-S81.
34. Gori G.B. A summary appraisal. Banbury Report: A Safe Cigarette? 1980, Cold Spring Harbor Laboratory, New York. G.B. Gori, F.G. Bock (Eds.).
35. Gori G.B., Lynch C.J. Analytical cigarette yields as predictors of smoke bioavailibility. Regul. Toxicol. Pharmacol. 1985, 5:314-326.
36. Hatsukami D.K., Gorvino G.A., Eissenberg T., Clark P.I., Lawrence D., Leichow S. Methods to assess potential reduced exposure products. Nicotine Tob. Res. 2005, 7:827-844.
37. Hatsukami D.K., Joseph A.M., LeSage M., Jensen J., Murphy S.E., Pentel P.R., Kotlyar M., Borgida E., Le C., Hecht S.S. Developing the science base for reducing tobacco harm. Nicotine Tob. Res. 2007, 9(Suppl. 4):S537-S553.
38. Hatsukami D.K., Biener L., Leischow S.J., Zeller M.R. Tobacco and nicotine product testing. Nicotine Tob. Res. 2012, 1:7-17.
39. Health Canada. (2000). Tobacco reporting regulations. Available at: http://www.hc-sc.gc.ca/hc-ps/pubs/tobac-tabac/tir-rft/report-eng.php#aconstituents.
40. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. Cancer 2003, 3:733-744.
41. Hecht S.S., Tricker A.R. Nitrosamine derived from nicotine and other tobacco alkaloids. Analytical Determination of Nicotine and Related Compounds and their Metabolites 1999, 421-488. Elsevier, Amsterdam. J.W. Gorrod, P. Jacob (Eds.).
42. Hecht S.S., McIntee E.J., Wang M. New DNA adducts of crotonaldehyde and acetaldehyde. Toxicology 2001, 166:31-36.
43. Institute of Medicine, 2001. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: The National Academy Press.
44. Institute of Medicine, 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academy Press.
45. International Agency for Research on Cancer, 1987. Overall evaluations of carcinogenicity: An update of IARC monographs volumes 1-42. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement No. 7, IARC, Lyon, France.
46. International Conference on Harmonization, 1995. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonized Tripartite Guideline: Guideline on specific aspects of regulatory genotoxicity tests for pharmaceuticals S2A. Geneva, Switzerland, IFPMA.
47. International Organization for Standardization, 2000. Routine analytical cigarette-smoking machine - definitions and standard conditions. Standard 3308, fourth ed., Geneva, International Organization for Standardization.
48. INVITTOX, 1990. Protocol No. 3a: the FRAME modified neutral red uptake cytotoxicity test. In: The ERGATT/FRAME data bank of in vitro techniques in toxicology. Nottingham, INVITTOX.
49. Jarvis M.J., Boreham R., Primatesta P., Feyerabend C., Bryant A. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J. Natl. Cancer Inst. 2001, 93:134-138.
50. Knorr, A., Monge, A., Stueber, M., Arndt, D., Stratmann, A., Martin, E., Peitsch, M., Pospisil, M. 2011. Computer-Assisted Structure Identification (CASI): High-throughput identification of small molecules by two-dimensional gas chromatography-mass spectrometry. Presented at the 2nd European GCxGC Symposium, Institute of Functional Genomics, University of Regensburg, Germany, 20-21 September 2011.
51. Kuenemann-Migeot C., Callais F., Momas I., Festy B. Use of salmonella typhimurium TA 98, YG 1024 and YG 1021 and deconjugating enzymes for evaluating the mutagenicity from smokers' urine. Mutat. Res. 1997, 390:283-291.
52. Lindner, D., Smith, S., Martin Leroy, C., Tricker, A.R., 2011. Comparison of exposure to selected cigarette smoke constituents in adult smokers and non-smokers in a European, multicenter, observational study. Cancer Epidemiol. Biomarkers Prev. 20, 1524-1536.
53. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
54. Martin Leroy C., Jarus-Dziedzic K., Ancerewicz J., Lindner D., Magnette J. Reduced exposure substantiation of an Electrically Heated Cigarette Smoking System. Part 7: A one-month, randomized, ambulatory, controlled clinical study in Poland. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S74-S84.
55. Mascher D.G., Mascher H.J., Scherer G., Schmid E.R. High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 750:163-169.
56. Matsuda Y., Hoffmann D. Quantitative determination of 1-naphthylamine and 2-naphthylamine in cigarette smoke. Anal. Chem. 1969, 41:650-652.
57. Medeiros A.M., Bird M.G., Witz G. Potential biomarkers of benzene exposure. J. Toxicol. Environ. Health 1997, 51:519-539.
58. Melikian A.A., Prahalad A.K., Hoffmann D. Urinary trans, trans-muconic acid as an indicator of exposure to benzene in cigarette smokers. Cancer Epidemiol. Biomarkers Prev. 1993, 2:47-51.
59. Mendes P., Liang Q., Frost-Pineda K., Munjal S., Walk R.A., Roethig H.J. The relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the US. Regul. Toxicol. Pharmacol. 2009, 55:17-27.
60. Moennikes O., Vanscheeuwijck P.M., Friedrichs B., Anskeit E., Patskan G.J. Reduced toxicological activity of cigarette smoke by the addition of ammonium magnesium phosphate to the paper of an electrically heated cigarette: subchronic inhalation toxicology. Inhal. Toxicol. 2008, 20:647-663.
61. Munjal S., Koval T., Muhammad R., Jin Y., Demmel V., Roethig H.J., Mendes P. Heart rate variability increases with reductions in cigarette smoke exposure after 3 days. J. Card. Pharmacol. Ther. 2009, 14:192-198.
62. Organization for Economic Co-operation and Development, 1997. Bacterial reverse mutation test. Test No. 471. In: OECD guidelines for testing of chemicals. Paris, OECD.
63. Patrianakos C., Hoffmann D. Chemical studies on tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smoke. J. Anal. Toxicol. 1979, 3:150-154.
64. Patskan G., Reininghaus W. Toxicological evaluation of an electrically heated cigarette. Part 1: Overview of technical concepts and summary of findings. J. Appl. Toxicol. 2003, 23:323-328.
65. Rieben F.W. Smoking behaviour and increase in nicotine and carboxyhaemoglobin in venous blood. Clin. Investig. 1992, 70:335-342.
66. Riedel K., Scherer G., Engl J., Hagedorn H.-W., Tricker A.R. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J. Anal. Toxicol. 2006, 30:187-195.
67. Rodgman A., Perfetti T.A. The Chemical Components of Tobacco and Tobacco Smoke 2009, CRC Press, Boca Raton.
68. Rodu B., Godshall W.T. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct. J. 2006, 3:37.
69. Roemer E., Stabbert R., Rustemeier K., Veltel D.J., Meisgen T.J., Reininghaus W., Carchman R., Gaworski C.L., Podrazza K.F. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoke under two sets of machine smoking conditions. Toxicology 2004, 195:31-52.
70. Roemer E., Stabbert R., Veltel D.J., Müller B.P., Meisgen T.J., Schramke H., Anskeit E., Elves R.G., Fournier J.A. Reduced toxicological activity of cigarette smoke by the addition of ammonium magnesium phosphate to the paper of an electrically heated cigarette: smoke chemistry and in vitro cytotoxicity and genotoxicity. Toxicol. In Vitro 2008, 22:671-681.
71. Roethig H.J., Kinser R.D., Lau R.W., Walk R.-A., Wang N. Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking. J. Clin. Pharmacol. 2005, 45:133-145.
72. Roethig H.J., Zedler B.K., Kinser R.D., Feng S., Nelson B.L., Liang Q. Short-term clinical exposure evaluation of a second generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 2007, 47:518-530.
73. Roethig H.J., Feng S., Liang Q., Liu J., Rees W.A., Zedler B.K. A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 2008, 48:580-591.
74. Royal College of Physicians and Surgeons, 2007. Harm reduction in nicotine addiction: helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians: London, UK.
75. Ruppert T., Scherer G., Tricker A.R., Adlkofer F. Trans, trans-Muconic acid as a biomarker of non-occupational environmental exposure to benzene. Int. Arch. Occup. Environ. Health 1997, 69:247-251.
76. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology 1999, 145:1-20.
77. Scherer G. Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Exp. Toxicol. Pathol. 2006, 58:101-114.
78. Scherer G., Engl J., Urban M., Gilch G., Janket D., Riedel K. Relationships between machine-dervived smoke yields and biomarkers in cigarette smokers in Germany. Regul. Toxicol. Pharmacol. 2007, 47:171-183.
79. Scherer G., Urban M., Hagedorn H.-W., Feng S., Kinser R.D., Sarkar M., Liang Q., Roethig H.J. Determination of two mercapturic acids related to crotonaldehyde in human urine: influence of smoking. Hum. Exp. Toxicol. 2007, 26:37-47.
80. Schorp, M.K., 2005. Summary of literature data on smoking topography. In: A review of human smoking behaviour data and machine smoking of cigarettes. Report of the AD HOC WG9 Smoking Behaviour Review Team to ISO/TC 126 WG 9. Pickworth, W., Houlgate, P., Schorp, M.K., Dixon, M., Borgerding, M., Zaatari, G. (Eds.). Available at: (accessed 27.09.2011). http://www.legacy.library.ucsf.edu/documentStore/m/q/t/mqt27a00/Smqt27a00.pdf.
81. Schramke H., Meisgen T.J., Tewes F.J., Gomm W., Roemer E. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette smoke particulate phase. Toxicology 2006, 227:193-210.
82. Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification, 2002. Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 4, 149-159.
83. Stabbert R., Voncken P., Rustemeier K., Haussmann H.-J., Roemer E., Schaffernicht H., Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 2: Chemical composition of mainstream smoke. J. Appl. Toxicol. 2003, 23:329-339.
84. Stevens J.F., Meier C.S. Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52:7-25.
85. Strickland P., Kang D., Sithisarankul P. Polycyclic aromatic hydrocarbon metabolites in urine as biomarkers of exposure and effect. Environ. Health Perspect. 1996, 104(Suppl. 5):927-932.
86. Sweanor D., Alcabes P., Drucker E. Tobacco harm reduction: how rational public policy could transform a pandemic. Int. J. Drug Policy 2007, 18:70-74.
87. Talhout R., Schulz T., Florek E., von Benthem J., Wester P., Opperhuizen A. Hazardous compounds in tobacco smoke. Int. J. Environ. Res. Public Health 2011, 8:613-628.
88. Terpstra P.M., Teredesai A., Vanscheeuwijck P.M., Verbeeck J., Schepers G., Radtke F., Kuhl P., Gomm W., Anskeit E., Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 4: Subchronic inhalation toxicology. J. Appl. Toxicol. 2003, 23:349-362.
89. Tewes F.J., Meisgen T.J., Veltel D.J., Roemer E., Patskan G. Toxicological evaluation of an electrically heated cigarette. Part 3: Genotoxicity and cytotoxicity of mainstream smoke. J. Appl. Toxicol. 2003, 23:341-348.
90. Torikai K., Uwano Y., Nakamori T., Tarora W., Takahashi H. Study on tobacco components involved in the pyrolytic generation of selected smoke constituents. Food Chem. Toxicol. 2005, 43:559-568.
91. Tricker A.R. Biomarkers derived from nicotine and its metabolites: a review. Beitr. Tabakforsch. Int. 2006, 22:147-175.
92. Tricker A.R., Schorp M.K., Urban H.-J., Leyden D.L., Hagedorn H.-W., Engl J., Urban M., Riedel K., Gilch G., Janket D., Scherer G. Comparison of environmental tobacco smoke concentrations generated by an Electrically Heated Cigarette Smoking System and a conventional cigarette. Inhal. Toxicol. 2009, 21:62-77.
93. Tricker A.R., Stewart A.J., Martin Leroy C., Lindner D., Schorp M.K., Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 3: 8-day randomized clinical trial in the U.K. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S35-S44.
94. Tricker A.R., Jang I.J., Martin Leroy C., Lindner D., Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: 8-day randomized clinical trial in Korea. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S45-S53.
95. Tricker A.R., Kanada S., Takada K., Martin Leroy C., Lindner D., Schorp M.K., Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-day randomized clinical trial in Japan. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S54-S63.
96. Tricker A.R., Kanada S., Lindner D., Martin Leroy C., Schorp M.K., Dempsey R. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-day randomized clinical trial of a menthol cigarette in Japan. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S64-S73.
97. Ueda K., Kawachi I., Nakamura M., Nogami H., Shirokawa N., Masui S., Okayama A., Oshima A. Cigarette nicotine yields and nicotine intake among Japanese male workers. Tob. Control 2002, 11:55-60.
98. Unverdorben M., van der Bijl A., Potgieter L., Liang Q., Meyer B.H., Roethig H.J. Effects of levels of cigarette exposure on symptom-limited spiroergometry. Prev. Cardiol. 2007, 10:83-91.
99. Unverdorben, M., van der Bijl, A., Potgieter, L., Venter, C., Munjal, S., Qiwei Liang, Meyer, B., Roethig, H.J., 2008. Effects of different levels of cigarette smoke exposure on prognostic heart rate and rate-pressure-product parameters. J. Cardiovasc. Pharmacol. Ther. 13, 175-182.
100. Unverdorben M., Mostert A., Munjal S., van der Bijl A., Potgieter L., Venter C., Liang Q., Meyer B., Roethig H.J. Acute effects of cigarette smoking on pulmonary function. Regul. Toxicol. Pharmacol. 2010, 57:241-246.
101. Urban H.-J., Gomm W., Schorp M.K. A modelling approach to develop machine smoking protocols reflecting human puffing behaviour for conventional cigarettes. Beitr. Tabakforsch. Int. 2008, 23:8-18.
102. Urban H.-J., Tricker A.R., Leyden D.E., Forte N., Zenzen V., Feuersenger A., Assink M., Kallischnigg G., Schorp M.K. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 8: Nicotine Bridging - estimating smoke constituent exposure by their relationships to both nicotine levels in mainstream smoke and in smokers. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S85-S97.
103. Urban M., Kavvadias D., Riedel K., Scherer G., Tricker A.R. Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal. Toxicol. 2006, 18:831-839.
104. US Consumer Products safety Commission in Consultation with the US Department of Health and Human Services, 1993. Toxicity plan 5. US Consumer Product Safety Commission.
105. US Department of Health and Human Services, 2010. A Report of the Surgeon General: How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking Attributable Disease. Department of Health and Human Services, Public Health Services, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Rockville, MD.
106. van Sittert N.J., Mergens H.J., Watson W.P., Boogaard P.J. Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment. Toxicol. Sci. 2000, 56:189-202.
107. Werley M.S., Freelin S.A., Wrenn S.E., Gerstenberg B., Roemer E., Schramke H., Van Miert E., Vanscheeuwijck P., Weber S., Coggins C.R.E. Smoke chemistry, in vitro and in vivo toxicology evaluations of the Electrically Heated Cigarette Smoking System series K. Regul. Toxicol. Pharmacol. 2008, 52:122-139.
108. World Health Organization, 2007. The scientific basis of tobacco product regulation. Report of a WHO Study Group (TobReg). WHO Technical Report Series 945, Geneva.
109. World Health Organization, 2008. The scientific basis of tobacco product regulation: Second report of a WHO Study Group (TobReg). Technical Report Series 951, Geneva.
110. Zeller M., Hatsukami D., Backinger C., Benowitz N., Biener L., Burns D., Clark P., Connolly G., Djordjevic M.V., Eissenberg T., Giovino G.A., Healton C., Hecht S.S., Henningfield J.E., Husten C., Kobus K., Leischow S., Levy D.T., Marcus S., Myers M.L., Parascandola M., Ponkshe P., Shields P.G., Slovic P., Sweanor D., Warner K.E. The strategic dialogue on tobacco harm reduction: A vision and blueprint for action in the United States. Tob. Control 2009, 18:324-332.
111. Zenzen V., Diekmann J., Gerstenberg B., Weber S., Wittke S., Schorp M.K. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 2: Smoke chemistry and in vitro toxicological evaluation using smoking regimens reflecting human puffing behavior. Regul. Toxicol. Pharmacol. 2012, 64(Suppl. 1):S11-S34.